Form 4: Pfizer Director Ronald E. Blaylock Reports Acquisition of Phantom Stock Units
SEC Form 4
Director Ronald E. Blaylock reports acquisition of phantom stock units as deferred compensation from Pfizer Inc.
Summary
- On April 25, 2024, Ronald E. Blaylock, a director of Pfizer Inc., acquired 8,115.598 phantom stock units.
- These units were granted pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Unit Award Plan for Non-Employee Directors.
- Each unit represents one phantom share of Pfizer's common stock.
- The price per share was $25.26.
- Following the transaction, Blaylock directly owns 58,627.024 phantom stock units.
- These units represent deferred director's compensation that are settled in cash or common stock at the director's election following retirement from the Board of Directors.
Sentiment
Score: 7
Explanation: The sentiment is neutral to positive. The filing reflects standard compensation practices and aligns director interests with the company's long-term performance.
Positives
- The acquisition of phantom stock units aligns the director's interests with the long-term performance of Pfizer.
- The deferred compensation plan is a common practice for non-employee directors.
Future Outlook
The phantom stock units will be settled in cash or common stock at the director's election following retirement from the Board of Directors.
Industry Context
Deferred compensation plans, including phantom stock units, are a common practice in corporate governance to align the interests of non-employee directors with the long-term success of the company. This encourages directors to make decisions that benefit shareholders over the long term.
Comparison to Industry Standards
- Many large pharmaceutical companies, such as Johnson & Johnson (JNJ) and Merck (MRK), utilize deferred compensation plans for their non-employee directors.
- These plans often include stock options, restricted stock units, or phantom stock units.
- The specific terms and conditions of these plans vary, but the underlying goal is to incentivize directors to act in the best interests of the company and its shareholders.
Stakeholder Impact
- The acquisition of phantom stock units aligns the director's interests with those of the shareholders, potentially leading to decisions that benefit the company's long-term value.
Key Dates
| Date | Description |
|---|---|
| 04/25/2024 | Date of transaction: Acquisition of phantom stock units. |
| 04/26/2024 | Date of report filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.